Connection

JOHN VIERLING to Hepatitis C

This is a "connection" page, showing publications JOHN VIERLING has written about Hepatitis C.
Connection Strength

2.102
  1. HCV RNA viral load assessments in the era of direct-acting antivirals. Am J Gastroenterol. 2013 Apr; 108(4):471-5.
    View in: PubMed
    Score: 0.308
  2. Hepatitis C virus viral assays in the direct-acting antiviral era. Clin Liver Dis. 2013 Feb; 17(1):27-45.
    View in: PubMed
    Score: 0.305
  3. Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis. Semin Immunopathol. 2013 Jan; 35(1):1-5.
    View in: PubMed
    Score: 0.302
  4. Hepatitis B and hepatitis C prevalence and treatment referral among Asian Americans undergoing community-based hepatitis screening. Am J Public Health. 2010 Apr 01; 100 Suppl 1:S118-24.
    View in: PubMed
    Score: 0.248
  5. Treatment of hepatitis C infection. Gastroenterol Clin North Am. 2006 Jun; 35(2):463-86.
    View in: PubMed
    Score: 0.192
  6. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. N Engl J Med. 2017 06 01; 376(22):2134-2146.
    View in: PubMed
    Score: 0.103
  7. Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation. J Viral Hepat. 1997; 4 Suppl 1:117-24.
    View in: PubMed
    Score: 0.100
  8. Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure. Hepatology. 1995 Nov; 22(5):1379-86.
    View in: PubMed
    Score: 0.092
  9. Recurrence of viral hepatitis after liver transplantation: insights into management. Liver Transpl Surg. 1995 Sep; 1(5 Suppl 1):89-99.
    View in: PubMed
    Score: 0.091
  10. The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosis. Gastroenterology. 2014 Aug; 147(2):366-76.e6.
    View in: PubMed
    Score: 0.083
  11. Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis. J Hepatol. 2013 Mar; 58(3):479-87.
    View in: PubMed
    Score: 0.075
  12. Direct detection of circulating hepatitis C virus RNA using probes from the 5' untranslated region. J Clin Invest. 1992 Jun; 89(6):2040-5.
    View in: PubMed
    Score: 0.073
  13. Hepatitis C therapy with long term remission after renal transplantation. Int J Artif Organs. 2002 Dec; 25(12):1189-93.
    View in: PubMed
    Score: 0.038
  14. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg. 1997 Jul; 3(4):398-406.
    View in: PubMed
    Score: 0.026
  15. Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction. Hum Pathol. 1996 Nov; 27(11):1161-5.
    View in: PubMed
    Score: 0.025
  16. Simultaneous detection of both hepatitis B virus DNA and hepatitis C virus RNA using a combined one-step polymerase chain reaction technique. Hepatology. 1995 Apr; 21(4):901-7.
    View in: PubMed
    Score: 0.022
  17. Molecular diagnostic techniques for viral hepatitis. Gastroenterol Clin North Am. 1994 Sep; 23(3):479-98.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.